Ares Capital Reports Q4/FY25 Results, Declares $0.48 Dividend, Extends $1B Buyback
ARCC is trading near its 52-week low of $18.26 (6.8% above the low) on elevated volume (2.4× avg).
Summary
Ares Capital reported Q4 and full-year 2025 financial results, declared a stable $0.48 dividend, and extended its $1.0 billion stock repurchase program, signaling continued operational strength and commitment to shareholder returns.
Key Events · Financing and Capital Events · ARCC
-
Q4 & FY 2025 Financial Results
Reported Q4 2025 GAAP net income of $0.41/share and Core EPS of $0.50/share, with full-year GAAP net income of $1.86/share and Core EPS of $2.01/share. Net Asset Value per share increased slightly to $19.94.
-
Dividend Declaration
Declared a first quarter 2026 dividend of $0.48 per share, maintaining a consistent payout to shareholders.
-
Stock Repurchase Program Extended
Authorized an amendment to extend its existing stock repurchase program, allowing for up to $1.0 billion in common stock repurchases until February 15, 2027.
-
Debt Refinancing Activity
Issued $750 million in 5.250% unsecured notes due 2031 and repaid $1.15 billion of 3.875% unsecured notes that matured in January 2026.
Analysis · ARCC · Unknown
This 8-K provides a comprehensive update on Ares Capital's financial performance and capital allocation strategy. While GAAP EPS and Core EPS saw a year-over-year decline, the company reported a slight increase in Net Investment Income for Q4 2025 and a modest rise in Net Asset Value per share. The declaration of a stable $0.48 per share dividend for Q1 2026, consistent with previous quarters, reinforces its commitment to shareholder returns. A key positive development is the extension of the $1.0 billion stock repurchase program, signaling management's confidence in the company's valuation and its intent to enhance shareholder value. Strong investment activity and a healthy backlog further underscore operational strength.
At the time of this filing, ARCC was trading at $19.51 on NASDAQ in the Unknown sector, with a market capitalization of approximately $13.7B. The 52-week trading range was $18.26 to $23.84. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.